Bioverativ Inc (BIVV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 1,168,500 | 887,400 | 560,300 | 134,400 | 0 |
| Cost of Goods | 279,600 | 237,900 | 52,900 | 34,700 | 400 |
| Gross Profit | 888,900 | 649,500 | 507,400 | 99,700 | -400 |
| Operating Expenses | 442,300 | 358,000 | 410,300 | 460,500 | 342,000 |
| Operating Income | 447,200 | 292,400 | 98,000 | -360,100 | -342,000 |
| Other Income | 4,700 | -500 | 600 | 1,100 | -2,000 |
| Pre-tax Income | 451,900 | 291,900 | 98,600 | -359,000 | -344,000 |
| Income Tax | 96,300 | -147,700 | -10,000 | 1,300 | 600 |
| Net Income Continuous | 355,600 | 439,600 | 108,600 | -360,300 | -344,600 |
| Net Income | $355,600 | $439,600 | $108,600 | $-360,300 | $-344,600 |
| EPS Basic Total Ops | 3.29 | 4.07 | 1.01 | -3.34 | N/A |
| EPS Basic Continuous Ops | 3.29 | 4.07 | 1.01 | -3.34 | N/A |
| EPS Diluted Total Ops | 3.28 | 4.07 | 1.01 | -3.34 | N/A |
| EPS Diluted Continuous Ops | 3.28 | 4.07 | 1.01 | -3.34 | N/A |
| EPS Diluted Before Non-Recurring Items | 2.74 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $461,700 | $345,800 | $113,600 | $-347,800 | $-331,400 |